Skip to content

Cigna likely suitor for Humana: Leerink

May 26, 2017

Leerink Partners maintains Outperform Humana (NYSE: HUM) price target of $265.00 (from $250.00)

Analyst Dr. Ana Gupte comments to clients that Humana is likely open for a sale and Cigna Corp. (NYSE: CI) is the most likely suitor. Price range for a possible deal according to Dr. Gupte is in the range of $260 to $270. Dr. Gupte also notes that Cigna may need to sell some assets, specifically Healthspring Medicare Advantage, to skirt any anti-trust concerns.


From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: